$397 Million is the total value of Samsara BioCapital, LLC's 57 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 15.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KDNY | CHINOOK THERAPEUTICS INC | $75,123,000 | +0.3% | 4,591,888 | 0.0% | 18.91% | +30.2% | |
| GRPH | Buy | GRAPHITE BIO INC | $41,170,000 | -57.8% | 8,072,603 | +2.8% | 10.36% | -45.3% |
| NKTX | Sell | NKARTA INC | $23,155,000 | -25.9% | 2,034,702 | -0.0% | 5.83% | -3.8% |
| TIL | INSTIL BIO INC | $21,413,000 | -37.2% | 1,991,950 | 0.0% | 5.39% | -18.5% | |
| ISEE | IVERIC BIO INC | $21,249,000 | +0.7% | 1,262,551 | 0.0% | 5.35% | +30.6% | |
| CNTA | Buy | CENTESSA PHARMACEUTICALS PLCsponsored ads | $16,900,000 | +2.8% | 1,884,096 | +29.1% | 4.26% | +33.4% |
| FMTX | FORMA THERAPEUTICS HLDGS INC | $14,559,000 | -34.6% | 1,565,526 | 0.0% | 3.66% | -15.1% | |
| New | ARCELLX INC | $14,016,000 | – | 999,727 | +100.0% | 3.53% | – | |
| STRO | SUTRO BIOPHARMA INC | $13,773,000 | -44.8% | 1,675,579 | 0.0% | 3.47% | -28.3% | |
| ACRS | ACLARIS THERAPEUTICS INC | $13,692,000 | +18.6% | 794,171 | 0.0% | 3.45% | +53.9% | |
| ICPT | INTERCEPT PHARMACEUTICALS IN | $10,424,000 | -0.1% | 640,688 | 0.0% | 2.62% | +29.6% | |
| RAIN | RAIN THERAPEUTICS INC | $7,967,000 | -60.6% | 1,571,379 | 0.0% | 2.01% | -48.9% | |
| ZYME | New | ZYMEWORKS INC | $6,360,000 | – | 970,987 | +100.0% | 1.60% | – |
| IO BIOTECH INC | $5,938,000 | -17.2% | 1,120,437 | 0.0% | 1.50% | +7.5% | ||
| JANX | JANUX THERAPEUTICS INC | $5,906,000 | -27.3% | 411,871 | 0.0% | 1.49% | -5.6% | |
| EYPT | EYEPOINT PHARMACEUTICALS INC | $5,832,000 | -0.7% | 480,000 | 0.0% | 1.47% | +28.8% | |
| VRNA | VERONA PHARMA PLCsponsored ads | $5,544,000 | -25.8% | 1,111,112 | 0.0% | 1.40% | -3.7% | |
| JYAC | JIYA ACQUISITION CORP | $4,984,000 | +0.6% | 507,041 | 0.0% | 1.26% | +30.6% | |
| IMCR | Buy | IMMUNOCORE HLDGS PLCads | $4,813,000 | +119.7% | 160,963 | +151.5% | 1.21% | +185.2% |
| SCIENCE 37 HOLDINGS INC | $4,815,000 | -57.1% | 900,000 | 0.0% | 1.21% | -44.3% | ||
| TANGO THERAPEUTICS INC | $4,775,000 | -30.7% | 630,000 | 0.0% | 1.20% | -10.1% | ||
| AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $4,504,000 | -15.5% | 659,409 | 0.0% | 1.13% | +9.7% | |
| ALXO | New | ALX ONCOLOGY HLDGS INC | $4,441,000 | – | 262,786 | +100.0% | 1.12% | – |
| SRRK | New | SCHOLAR ROCK HLDG CORP | $4,378,000 | – | 339,611 | +100.0% | 1.10% | – |
| New | DICE THERAPEUTICS INC | $4,371,000 | – | 228,466 | +100.0% | 1.10% | – | |
| IGMS | New | IGM BIOSCIENCES INC | $4,134,000 | – | 154,664 | +100.0% | 1.04% | – |
| RYTM | RHYTHM PHARMACEUTICALS INC | $3,978,000 | +15.4% | 345,293 | 0.0% | 1.00% | +49.6% | |
| RXRX | RECURSION PHARMACEUTICALS INcl a | $3,861,000 | -58.2% | 539,236 | 0.0% | 0.97% | -45.8% | |
| VIRX | VIRACTA THERAPEUTICS INC | $3,385,000 | +30.4% | 711,039 | 0.0% | 0.85% | +69.4% | |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $3,341,000 | -61.6% | 59,204 | -57.8% | 0.84% | -50.1% |
| ALBO | ALBIREO PHARMA INC | $2,983,000 | +28.1% | 100,000 | 0.0% | 0.75% | +66.2% | |
| BLSA | BCLS ACQUISITION CORP | $2,961,000 | +0.7% | 300,000 | 0.0% | 0.74% | +30.7% | |
| BOLT | Buy | BOLT BIOTHERAPEUTICS INC | $2,875,000 | -20.4% | 1,049,153 | +42.3% | 0.72% | +3.3% |
| DBTX | DECIBEL THERAPEUTICS INC | $2,512,000 | -34.6% | 826,422 | 0.0% | 0.63% | -15.3% | |
| ELEV | ELEVATION ONCOLOGY INC | $2,349,000 | -58.1% | 932,240 | 0.0% | 0.59% | -45.7% | |
| AMYT | New | AMRYT PHARMA PLCsponsored ads | $2,313,000 | – | 279,715 | +100.0% | 0.58% | – |
| SYRS | Sell | SYROS PHARMACEUTICALS INC | $2,261,000 | -63.8% | 1,899,616 | -13.2% | 0.57% | -53.0% |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $2,033,000 | -51.6% | 883,720 | 0.0% | 0.51% | -37.1% | |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | $2,009,000 | -41.1% | 202,500 | 0.0% | 0.51% | -23.6% | |
| NVAX | NOVAVAX INC | $1,999,000 | -48.5% | 27,144 | 0.0% | 0.50% | -33.2% | |
| EQ | EQUILLIUM INC | $1,939,000 | -16.5% | 615,541 | 0.0% | 0.49% | +8.4% | |
| NVAX | Sell | NOVAVAX INCcall | $1,723,000 | -85.4% | 23,400 | -71.7% | 0.43% | -81.1% |
| BCEL | ATRECA INC | $1,258,000 | +4.7% | 396,835 | 0.0% | 0.32% | +36.1% | |
| VTVT | VTV THERAPEUTICS INCcl a | $1,181,000 | -27.4% | 1,635,509 | 0.0% | 0.30% | -6.0% | |
| ALLK | ALLAKOS INC | $981,000 | -41.8% | 172,089 | 0.0% | 0.25% | -24.5% | |
| ODT | ODONATE THERAPEUTICS INC | $925,000 | -2.2% | 700,421 | 0.0% | 0.23% | +26.6% | |
| SURROZEN INC | $903,000 | -53.3% | 300,000 | 0.0% | 0.23% | -39.5% | ||
| TERN | TERNS PHARMACEUTICALS INC | $859,000 | -58.0% | 289,068 | 0.0% | 0.22% | -45.6% | |
| KALA | KALA PHARMACEUTICALS INC | $830,000 | +14.2% | 601,162 | 0.0% | 0.21% | +48.2% | |
| BNTX | BIONTECH SEsponsored ads | $688,000 | -33.8% | 4,031 | 0.0% | 0.17% | -14.4% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $643,000 | -27.3% | 40,550 | 0.0% | 0.16% | -5.8% | |
| VTGN | VISTAGEN THERAPEUTICS INC | $606,000 | -36.4% | 488,632 | 0.0% | 0.15% | -17.3% | |
| KRON | KRONOS BIO INC | $565,000 | -46.8% | 78,131 | 0.0% | 0.14% | -31.1% | |
| ALVR | ALLOVIR INC | $556,000 | -47.8% | 82,336 | 0.0% | 0.14% | -32.4% | |
| NGM | NGM BIOPHARMACEUTICALS INC | $208,000 | -14.0% | 13,669 | 0.0% | 0.05% | +10.6% | |
| ASTRIA THERAPEUTICS INC | $168,000 | +24.4% | 25,000 | 0.0% | 0.04% | +61.5% | ||
| AMRN | AMARIN CORP PLCspons adr new | $82,000 | -2.4% | 25,000 | 0.0% | 0.02% | +31.2% | |
| ALLK | Exit | ALLAKOS INCcall | $0 | – | -168,200 | -100.0% | -0.32% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Intercept Pharmaceuticals Inc | 20 | Q3 2023 | 24.0% |
| ALLAKOS INC | 20 | Q3 2023 | 23.0% |
| SUTRO BIOPHARMA INC | 20 | Q3 2023 | 10.1% |
| SYROS PHARMACEUTICALS INC | 16 | Q3 2022 | 11.6% |
| ATRECA INC | 16 | Q1 2023 | 7.4% |
| IVERIC BIO INC | 15 | Q2 2023 | 5.5% |
| ACLARIS THERAPEUTICS INC | 15 | Q3 2023 | 4.8% |
| RHYTHM PHARMACEUTICALS INC | 15 | Q3 2023 | 2.4% |
| ODONATE THERAPEUTICS INC | 14 | Q1 2022 | 14.9% |
| SPRINGWORKS THERAPEUTICS INC | 14 | Q4 2022 | 12.1% |
View Samsara BioCapital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR/A | 2023-02-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Samsara BioCapital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.